Fruquintinib 1194506-26-7 Fruquintinib (HMPL-013) is a small molecule vascular endothelial growth factor receptors inhibitor.

CEP37440 1391712-60-9 CEP-37440 is a novel potent and selective Dual FAK/ALK inhibitor with IC50 s of 2.3 nM (FAK) and 120 nM(ALK cellular IC50 in 75% human plasma).

MI-2 (Menin-MLL Inhibitor) 1271738-62-5 MI-2 (Menin-MLL Inhibitor) is a potent menin-MLL interaction inhibitor with IC50 of 446 nM.

HA130 1229652-21-4 HA130 is a selective ATX (autotaxin) inhibitor with IC50 of 28 nM.

KRCA-0008 1472795-20-2 KRCA-0008 is a potent and selective ALK/Ack1 inhibitor with IC50 of 12 nM/4 nM for ALK and Ack1 respectively; displays drug-like properties without hERG liability.

Exherin (ADH-1) 229971-81-7 Exherin (ADH-1) is a small, cyclic pentapeptide vascular-targeting agent with potential antineoplastic and antiangiogenic activities;

A-1210477 1668553-26-1 A-1210477 is a potent and selective MCL-1 and Bcl-2 inhibitor with Ki and IC50 of 0.454 nM and 26.2 nM, respectively, 100-fold selectivity over other Bcl-2 family members.

UNC2881 1493764-08-1 UNC2881 is a specific Mer tyrosine kinase inhibitor with IC50 of 4.3 nM, about 83- and 58-fold selectivity over Axl and Tyro3, respectively.